← Back to Search

Family Health History Education for Hereditary Diseases in the Black Community (FHH Trial)

N/A
Waitlist Available
Led By Kent D Key, PhD
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 and older
Age 18 and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

FHH Trial Summary

This trial will create a culturally tailored Family Health History tool to inform and empower African Americans about health risks related to their family genealogy. The goal is to increase preventative behaviors and link people to needed health services to prevent the onset of disease and illness.

Who is the study for?
This trial is for English-speaking African American adults who are interested in learning about their family health history to prevent hereditary diseases and genetic disorders. It's not open to those under 18, non-English speakers, or individuals who do not identify as African American.Check my eligibility
What is being tested?
The study is testing a culturally tailored education program designed with input from the African American community. The goal is to increase awareness and use of Family Health Histories for better prevention and linkage to health services.See study design
What are the potential side effects?
Since this intervention involves an educational program rather than a medical treatment, traditional physical side effects are not expected. However, participants may experience emotional or psychological responses when discussing family health histories.

FHH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am 18 years old or older.
Select...
I speak English.

FHH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability: Client Satisfaction Questionnaire (CSQ-8-R)
Acceptability: End of Intervention/Treatment Questionnaire
Feasibility: Client Satisfaction Questionnaire (CSQ-8-R)
+4 more
Secondary outcome measures
Number of screenings requested
Satisfaction with Family Health History
Understandability
Other outcome measures
Health communication
Health literacy

FHH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: African American Family Health History Education ProgramExperimental Treatment1 Intervention
The AAFHHEP arm is an intervention to increase utilization of FHH and increase preventative screening. This tool will be culturally tailored by African Americans for African Americans.
Group II: Genetic Alliance: Does it run in the familyActive Control1 Intervention
The Genetic Alliance Does it run in the family is an existing family health history tool kit generalized to all racial groups. This tool is widely available via the internet.

Find a Location

Who is running the clinical trial?

Michigan State UniversityLead Sponsor
183 Previous Clinical Trials
601,027 Total Patients Enrolled
Kent D Key, PhDPrincipal InvestigatorMichigan State University

Media Library

African American Family Health History Education Program Clinical Trial Eligibility Overview. Trial Name: NCT05358964 — N/A
Hereditary Diseases Research Study Groups: Genetic Alliance: Does it run in the family, African American Family Health History Education Program
Hereditary Diseases Clinical Trial 2023: African American Family Health History Education Program Highlights & Side Effects. Trial Name: NCT05358964 — N/A
African American Family Health History Education Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05358964 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to partake in this trial?

"Reports hosted on clinicaltrials.gov suggest that this medical study, which was initially posted in May of 2022 and last updated shortly thereafter, has concluded its recruitment period. However, there are still 45 other studies actively seeking out potential participants at the time of writing."

Answered by AI
~67 spots leftby Jan 2026